miRoncol is developing an innovative technology to screen 12+ solid tumor cancers in one blood test. Based on microRNA (miRNA), it is highly accurate, highly affordable, and highly accessible using widely available PCR equipment. Enabled by breakthrough technology, miRoncol aims to democratize access to early cancer detection and save lives from cancer.
Company Details
- Employees
- 8
- Founded
- 2021
- Address
- 1000 Innovation Dr, 5f,canada
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
- Website
- https://www.mironcol.com
- Keywords
- Bioinformatics, Multi-cancer Early Detection, Cancer Screening, Liquid Biopsy, Oncology, MicroRNA.
- HQ
- Kanata, Ontario
Mironcol Questions
Mironcol's website is https://www.mironcol.com
Mironcol's LinkedIn profile is https://ca.linkedin.com/company/mironcol
Mironcol has
8 employees.
View email and phone details for 8
employees at Mironcol.
Mironcol's industry is
Health and Human Services
Mironcol's top competitors are
Aihearu,
Body M3canix, Inc.,
Dicerra,
Diagnostics Biochem Canada (Dbc),
Multicloud Decentralized Applications Inc.,
Leynek Medical,
Gatehouse Bio,
Cleaninnogen Energy Solutions,
Medbiome,
Cheo Research Institute.
Mironcol's categories are Health and Human Services
Mironcol's founding year is 2021
